Page last updated: 2024-09-05

nk3201 and Graft Occlusion, Vascular

nk3201 has been researched along with Graft Occlusion, Vascular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, M; Takai, S1
Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Nishimoto, M; Sakaguchi, M; Sasaki, S; Sukenaga, Y; Takai, S; Yuda, A1

Reviews

1 review(s) available for nk3201 and Graft Occlusion, Vascular

ArticleYear
Application of a chymase inhibitor, NK3201, for prevention of vascular proliferation.
    Cardiovascular drug reviews, 2003,Fall, Volume: 21, Issue:3

    Topics: Acetamides; Angioplasty, Balloon; Angiotensin II; Animals; Cell Division; Chymases; Endothelium, Vascular; Graft Occlusion, Vascular; Humans; Hypertension; Protease Inhibitors; Pyrimidines; Serine Endopeptidases; Vascular Diseases

2003

Other Studies

1 other study(ies) available for nk3201 and Graft Occlusion, Vascular

ArticleYear
Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein.
    Life sciences, 2001, Aug-31, Volume: 69, Issue:15

    Topics: Acetamides; Administration, Oral; Angiotensin I; Animals; Carotid Arteries; Cell Division; Chymases; Culture Techniques; Dogs; Drug Antagonism; Graft Occlusion, Vascular; Muscle Contraction; Peptidyl-Dipeptidase A; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Species Specificity; Veins

2001